Should It Be Easier or Harder to Use Unapproved Drugs and Devices?

Hastings Center Report 16 (1):17-23 (1986)
  Copy   BIBTEX

Abstract

In applying statutory safeguards, the FDA must not regulate investigational new products so stringently that a life‐saving therapy is unavailable. But the agency must also protect dying patients from exploitation by unscrupulous or overzealous researchers. The balance between individual choice and public protection has been questioned in cases involving experimental AIDS drugs and an artificial heart.

Categories

Keywords

Reprint years

2012

DOI

10.2307/3562465

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,574

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The Legal Status of Unapproved Generic Drugs.Richard R. Abood - 1982 - Journal of Law, Medicine and Ethics 10 (1):24-28.
Crimes, Regulatory Offences and Criminal Trials.R. A. Duff - 2007 - In Müller-Dietz H. (ed.), Festschrift für Heike Jung. Nomos Verlagsgesellschaft. pp. 87-98.
Crimes, Regulatory Offences and Criminal Trials.Antony Duff - unknown
Terminal illness and access to phase 1 experimental agents, surgeries and devices: Reviewing the ethical arguments.Udo Schüklenk & Christopher Lowry - 2009 - British Medical Bulletin 89 (1):7-22.
The Right to Stay Alive?Madeleine Blot - unknown
Commentary: Evaluating Oversight of Human Drugs and Medical Devices.Susan Bartlett Foote - 2009 - Journal of Law, Medicine and Ethics 37 (4):629-632.
Commentary: Public Outreach by the FDA: Evaluating Oversight of Human Drugs and Medical Devices.Mark S. Frankel - 2009 - Journal of Law, Medicine and Ethics 37 (4):625-628.
ASLM Conference on Medical Products, Devices and Drugs Held in Boston, June 21?22, 1976.Shirley G. Yerkes - 1976 - Journal of Law, Medicine and Ethics 4 (3):12-13.
Sex and drugs: Do women differ from men in their subjective response to drugs of abuse?Susan C. Han & Suzette M. Evans - 2005 - In Mitch Earleywine (ed.), Mind-Altering Drugs. Oxford University Press.
Psychedelic, psychoactive, and addictive drugs and states of consciousness.Ralph Metzner - 2005 - In Mitch Earleywine (ed.), Mind-Altering Drugs: The Science of Subjective Experience. Oxford University Press. pp. 25-48.
Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology.Jordan Paradise, Alison W. Tisdale, Ralph F. Hall & Efrosini Kokkoli - 2009 - Journal of Law, Medicine and Ethics 37 (4):598-624.
But it is easy to assemble a list of criticisms; it is much harder to write a really good book. In this latter, harder task, John Kekes has, once more, succeeded admirably.Timothy Chappell - 2012 - Mind 121 (483):483.
Framing Responsibility: HIV, Biomedical Prevention, and the Performativity of the Law.Kane Race - 2012 - Journal of Bioethical Inquiry 9 (3):327-338.
Derrida and drugs.Tim Gough - unknown

Analytics

Added to PP
2013-11-22

Downloads
10 (#1,201,046)

6 months
2 (#1,206,551)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references